PMID- 35571968 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 2325-9671 (Print) IS - 2325-9671 (Electronic) IS - 2325-9671 (Linking) VI - 10 IP - 5 DP - 2022 May TI - Effect of Cigarette Smoking on Midterm Outcomes After Arthroscopic Surgery for Femoroacetabular Impingement Syndrome: A Propensity-Matched Controlled Study With Minimum 5-Year Follow-up. PG - 23259671221090905 LID - 10.1177/23259671221090905 [doi] LID - 23259671221090905 AB - BACKGROUND: There is limited literature evaluating patient-reported outcomes (PROs) in cigarette smokers undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) at midterm follow-up. PURPOSE: (1) To report minimum 5-year PROs for cigarette-smoking patients who underwent primary hip arthroscopy for FAIS and (2) to compare these results with a propensity-matched control group of never-smoking patients. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Data were collected for all patients who underwent primary hip arthroscopy for FAIS between June 2009 and March 2016. Patients were eligible if they indicated that they smoked cigarettes within 1 month of surgery and had minimum 5-year postoperative outcomes for the modified Harris Hip Score, Nonarthritic Hip Score, Hip Outcome Score-Sport Specific Subscale (HOS-SSS), and International Hip Outcome Tool-12 (iHOT-12). The percentages of patients achieving the Patient Acceptable Symptom State (PASS) and maximum outcome improvement satisfaction threshold were recorded. The study group was then propensity matched in a 1:2 ratio to patients who had never smoked for comparison. RESULTS: Included were 35 patients (35 hips) with a mean age of 39.4 +/- 13.0 years and mean follow-up of 64.6 +/- 4.1 months. These patients demonstrated significant improvement from preoperatively to a minimum 5-year follow-up for all recorded PROs (P < .05). When compared with 70 control patients (70 hips), smoking patients demonstrated significantly worse preoperative scores for all PROs (P < .05). Study patients also demonstrated worse minimum 5-year scores for all recorded PROs compared with control patients, which did not reach statistical significance but trended toward significance for HOS-SSS (70.4 vs 81.9; P = .076) and iHOT-12 (74.7 vs 82.2; P = .122). Smoking patients also trended toward lower rates of achieving PASS for the iHOT-12 compared with never-smoking patients (50.0% vs 68.2%; P = .120). CONCLUSION: Patients who smoked cigarettes and underwent primary hip arthroscopy for FAIS demonstrated significant improvement in PROs at a minimum 5-year follow-up. When compared with a propensity-matched control group of never-smokers, they trended toward lower postoperative HOS-SSS and iHOT-12 scores and lower rates of achieving PASS on the iHOT-12. CI - (c) The Author(s) 2022. FAU - Jimenez, Andrew E AU - Jimenez AE AD - American Hip Institute Research Foundation, Chicago, Illinois, USA. FAU - Lee, Michael S AU - Lee MS AD - American Hip Institute Research Foundation, Chicago, Illinois, USA. FAU - Owens, Jade S AU - Owens JS AD - American Hip Institute Research Foundation, Chicago, Illinois, USA. FAU - Maldonado, David R AU - Maldonado DR AD - American Hip Institute Research Foundation, Chicago, Illinois, USA. FAU - Saks, Benjamin R AU - Saks BR AD - American Hip Institute Research Foundation, Chicago, Illinois, USA. FAU - Lall, Ajay C AU - Lall AC AD - American Hip Institute Research Foundation, Chicago, Illinois, USA. AD - American Hip Institute, Chicago, Illinois, USA. FAU - Domb, Benjamin G AU - Domb BG AD - American Hip Institute Research Foundation, Chicago, Illinois, USA. AD - American Hip Institute, Chicago, Illinois, USA. LA - eng PT - Journal Article DEP - 20220510 PL - United States TA - Orthop J Sports Med JT - Orthopaedic journal of sports medicine JID - 101620522 PMC - PMC9098985 OTO - NOTNLM OT - FAIS OT - hip arthroscopy OT - midterm outcomes OT - smoking COIS- One or more of the authors has declared the following potential conflict of interest or source of funding: A.E.J. has received education payments from Medwest. D.R.M. has received hospitality payments from Arthrex, Stryker, and Smith & Nephew. B.R.S. has received grants from Arthrex, education payments from Medwest and Smith & Nephew, and speaker fees from DJO Global. A.C.L. has received research support from Arthrex, Stryker, and Medacta; education payments from Medwest and Smith & Nephew; consulting fees from Arthrex and Graymont Medical; speaking fees from Arthres; and hospitality payments from Zimmer Biomet. B.G.D. has received research support from Arthrex, the Kauffman Foundation, and Stryker; consulting fees from Adventist Hinsdale Hospital, Arthrex, Medacta, and Stryker; education payments from Arthrex, Breg, and Medacta; speaking fees from Arthrex; honoraria from Medacta; royalties from Amplitude, Arthrex, DJO Global, Medacta, Stryker, and Orthomerica; and hospitality payments from Zimmer Biomet; and has had ownership interests in the American Hip Institute, Hinsdale Orthopaedics, SCD#3, North Shore Surgical Suites, and Munster Specialty Surgery Center. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto. EDAT- 2022/05/17 06:00 MHDA- 2022/05/17 06:01 PMCR- 2022/05/10 CRDT- 2022/05/16 04:05 PHST- 2021/11/01 00:00 [received] PHST- 2021/11/08 00:00 [accepted] PHST- 2022/05/16 04:05 [entrez] PHST- 2022/05/17 06:00 [pubmed] PHST- 2022/05/17 06:01 [medline] PHST- 2022/05/10 00:00 [pmc-release] AID - 10.1177_23259671221090905 [pii] AID - 10.1177/23259671221090905 [doi] PST - epublish SO - Orthop J Sports Med. 2022 May 10;10(5):23259671221090905. doi: 10.1177/23259671221090905. eCollection 2022 May.